Key facts
- This page summarizes Andrew C. Sagliocca's Form 4 filing for Esquire Financial Holdings, Inc. (ESQ).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 21 Sep 2026, 14:06.
Andrew C. Sagliocca - 18 Sep 2026 Form 4 Insider Report for Esquire Financial Holdings, Inc. (ESQ)
- Reporting relationship
- Vice Chairman, President & CEO, Director
- Issuer ticker
- ESQ
- Reported as of
- 18 Sep 2026
- Net transaction value
- -$1,227,300
- SEC form
- 4
- Accepted by SEC
- 21 Sep 2026, 14:06:40 UTC
- Prior SEC filing
- 02 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Eric S. Bader, pursuant to power of attorney
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Andrew C. Sagliocca filed Form 4 for Esquire Financial Holdings, Inc. (ESQ) on 21 Sep 2026.
Change
- Previous filing in this sequence was filed on 02 Feb 2026.
- Current net transaction value: -$1,227,300.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001709867
Primary reporting owner
Sagliocca Andrew C
- Relationship
- Vice Chairman, President & CEO, Director
- Address
- 100 JERICHO QUADRANGLE, SUITE 100, JERICHO
- Signature
- /s/ Eric S. Bader, pursuant to power of attorney
- Signature date
- 21 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ESQ
transaction
Common Stock
Sale
- Transaction value
- -$1,227,300
- Shares
- -10,000
- Change %
- -3.3%
- Price
- $122.73
- Shares after
- 288,798
- Date
- 18 Sep 2026
- Ownership
- Direct
- Footnotes
- F1, F2, F3, F4, F5, F6, F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.61 to $123.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
Footnote F2
Includes shares of restricted stock which vest in three equal annual installments commencing on December 16, 2024.
Footnote F3
Includes shares of restricted stock which vest in three equal annual installments commencing on December 9, 2025.
Footnote F4
Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2026.
Footnote F5
Includes shares of restricted stock which vest in three equal annual installments commencing on December 15, 2027.
Footnote F6
Includes shares of restricted stock which vest in three equal annual installments commencing on January 30, 2028.
Footnote F7
Includes shares of restricted stock which vest in three equal annual installments commencing on January 29, 2029.